JohnF.RobertsonIIIMD

PubMed

• erbB3 recruitment of insulin receptor substrate-1 impacts on insulin-like growth factor receptor signalling in oestrogen receptor positive breast cancer cell lines.
  Knowlden, J.M., Gee, J.M., Barrow, D., Robertson, J.F., Ellis, I.O., Nicholson, R.I., Hutcheson, I.R.> ;Breast Cancer Res. 2011
• Clinical relevance of withdrawal therapy as a form of hormonal manipulation for breast cancer.
  Agrawal, A.,Robertson, J. F.,Cheung, K. L.> ;World J Surg Oncol. 2011
• Nuclear and cytoplasmic expression of ERbeta1, ERbeta2, and ERbeta5 identifies distinct prognostic outcome for breast cancer patients.
  Shaaban, A.M., Green, A.R., Karthik, S., Alizadeh, Y., Hughes, T.A., Harkins, L., Ellis, I.O., Robertson, J.F., Paish, E.C., Saunders, P.K., Groome, N.P., Speirs, V.> ;Clin Cancer Res. 2008 Aug 15
• Prognostic markers in triple-negative breast cancer.
  Rakha, E.A., El-Sayed, M.E., Green, A.R., Lee, A.S., Robertson, J.F., Ellis, I.O.> ;Cancer. 2007 Jan 1
• Nuclear targeting of a midregion PTHrP fragment is necessary for stimulating growth in breast cancer cells.
  Kumari, R., Robertson, J.F., Watson, S.A.> ;Int J Cancer. 2006 Jul 1
• Epidermal growth factor receptor status in operable invasive breast cancer: is it of any prognostic value?
  Rampaul, R.S., Pinder, S.E., Wencyk, P.M., Nicholson, R.I., Blamey, R.W., Robertson, J.F., Ellis, I.O.> ;Clin Cancer Res. 2004 Apr 1
• Analysis of the level of mRNA expression of the membrane regulators of complement, CD59, CD55 and CD46, in breast cancer.
  Rushmere, N.K., Knowlden, J.M., Gee, J.W., Harper, M.E., Robertson, J.F., Morgan, B.P., Nicholson, R.I.> ;Int J Cancer. 2004 Mar 1
• Estrogen receptor downregulators: new antihormonal therapy for advanced breast cancer.
  Robertson, J.F.> ;Clin Ther. 2002
• Join now to see all